Top-Rated Charity
View similar charities
Ratings & Metrics
Financial Documents
Entity | Document Type | Tax ID |
---|---|---|
Ovarian Cancer Research Fund Alliance | Audited Consolidated Financial Statements | 13-3806788 |
Ovarian Cancer Research Fund Alliance | IRS Form 990 | 13-3806788 |
Entity: Ovarian Cancer Research Fund Alliance Document Type: Audited Consolidated Financial Statements Tax ID: 13-3806788 |
Entity: Ovarian Cancer Research Fund Alliance Document Type: IRS Form 990 Tax ID: 13-3806788 |
Governance & Transparency
CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
Top Salaries
Name | Title | Compensation | |
---|---|---|---|
1 | Audra L. Moran | President/CEO | $289,068 |
2 | Jonathan Zeidman | VP, Development | $164,025 |
3 | Roberta Franklin | VP, Marketing & Communications | $159,929 |
1 Name: Audra L. Moran Title: President/CEO Compensation: $289,068 |
2 Name: Jonathan Zeidman Title: VP, Development Compensation: $164,025 |
3 Name: Roberta Franklin Title: VP, Marketing & Communications Compensation: $159,929 |
Analysts' Notes
CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
According to the Ovarian Cancer Research Fund Alliance consolidated audit of December 31, 2017 (Note 1, Nature of Operations): "The Ovarian Cancer Research Fund, Inc. D/B/A Ovarian Cancer Research Fund Alliance ('OCRFA') is a corporation which was organized in the State of New York as a not-for-profit entity on December 8, 1994. OCRFA previously operated as the Ovarian Cancer Research Fund, Inc. ('OCRF'), and adopted its present name on January 1, 2016, the date on which the operations of the Ovarian Cancer National Alliance ('OCNA') were merged with OCRF's by the transfer of all of the operating assets and liabilities of OCNA to OCRFA. As a result of the transaction, OCRFA acquired, on a consolidated basis, net assets of $992,635, of which $348,020 were temporarily restricted." CharityWatch's rating of Ovarian Cancer Research Alliance for the fiscal year ended 12/31/17 is based on the financial activities of the consolidated entity that resulted from the merger between OCRF and OCNA. |
According to the Ovarian Cancer Research Fund Alliance consolidated audit of December 31, 2017 (Note 2, Concentrations of Credit Risk): "Included in the contributions of $6,526,826 for the year ended December 31, 2017 is a donation from the late Sol Schreiber, the founder of OCRF [Ovarian Cancer Research Fund], totaling approximately $1,300,000." [The $1,300,000 is about 20% of $6,526,826.] |
According to the Ovarian Cancer Research Fund Alliance consolidated audit of December 31, 2017 (Note 1, Contributed Services), the Alliance received in-kind contributed services in 2017 for "advertising services and professional fees" on which it placed a total value of $539,382. [Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.] |